Dr Feby Savira

Virtual Care Initiatives for Older Adults in Australia: Scoping Review

F Savira, A Gupta, C Gilbert, C Huggins, C Browning, W Chapman, T Haines, A Peeters

(2023), Vol. 25, pp. e38081-, Journal of medical Internet research, Canada, C1

Use of General Practitioner Telehealth Services During the COVID-19 Pandemic in Regional Victoria, Australia: Retrospective Analysis

F Savira, L Orellana, M Hensher, L Gao, A Sanigorski, K Mc Namara, V Versace, J Szakiel, J Swann, E Manias, A Peeters

(2023), Vol. 25, pp. e39384-, Journal of medical Internet research, Canada, C1

Knowledge, attitudes and practices of COVID-19 in rural Bangladesh: a cross-sectional study

B Siddiquea, A Afroz, M Chowdhury, F Savira, S Alif, O Bhattacharya, M Hossain, L Ali, H Chowdhury, A Shetty, M Islam, B Billah

(2023), Vol. 13, pp. 1-15, BMJ Open, London, Eng., C1

Consumer preferences for telehealth in Australia: A discrete choice experiment

Feby Savira, Suzanne Robinson, Kaylie Toll, Lauren Spark, Elizabeth Thomas, Julia Nesbitt, Isobel Frean, Richard Norman

(2023), Vol. 18, pp. 1-15, PLOS ONE, San Francisco, Calif., C1

Evaluation of COVID-19 vaccine acceptance and uptake in rural Bangladesh: a cross-sectional study

F Savira, S Alif, A Afroz, B Siddiquea, A Shetty, H Chowdhury, O Bhattacharya, M Chowdhury, M Islam, L Ali, B Billah

(2022), Vol. 12, pp. e064468-, BMJ open, England, C1

The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate

F Savira, A Kompa, D Kelly, R Magaye, X Xiong, L Huang, D Liew, C Reid, D Kaye, C Scullino, S Pitson, B Flynn, B Wang

(2021), Vol. 141, Vascular Pharmacology, United States, C1

The preventable productivity burden of kidney disease in Australia

F Savira, Z Ademi, B Wang, A Kompa, A Owen, D Liew, E Zomer

(2021), Vol. 32, pp. 938-949, Journal of the American Society of Nephrology, Washington, D.C., C1

Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition

F Savira, R Magaye, C Scullino, B Flynn, S Pitson, D Anderson, D Creek, Y Hua, X Xiong, L Huang, D Liew, C Reid, D Kaye, A Kompa, B Wang

(2021), Vol. 350, pp. 133-142, Toxicology Letters, Netherlands, C1

Dihydrosphingosine driven enrichment of sphingolipids attenuates TGFβ induced collagen synthesis in cardiac fibroblasts

R Magaye, F Savira, X Xiong, K Huynh, P Meikle, C Reid, B Flynn, D Kaye, D Liew, B Wang

(2021), Vol. 35, IJC Heart and Vasculature, Ireland, C1

Attenuating PI3K/Akt- mTOR pathway reduces dihydrosphingosine 1 phosphate mediated collagen synthesis and hypertrophy in primary cardiac cells

R Magaye, F Savira, Y Hua, X Xiong, L Huang, C Reid, B Flynn, D Kaye, D Liew, B Wang

(2021), Vol. 134, International Journal of Biochemistry and Cell Biology, Netherlands, C1

Apoptosis signal-regulating kinase 1 inhibition reverses deleterious indoxyl sulfate-mediated endothelial effects

F Savira, A Kompa, R Magaye, X Xiong, L Huang, B Jucker, R Willette, D Kelly, B Wang

(2021), Vol. 272, Life Sciences, Netherlands, C1

The impact of coronary heart disease prevention on work productivity: A 10-year analysis

F Savira, B Wang, A Kompa, Z Ademi, A Owen, D Liew, E Zomer

(2021), Vol. 28, pp. 418-425, European Journal of Preventive Cardiology, Oxford, Eng., C1

Cost-effectiveness of dapagliflozin in chronic heart failure: An analysis from the Australian healthcare perspective

F Savira, B Wang, A Kompa, Z Ademi, A Owen, S Zoungas, A Tonkin, D Liew, E Zomer

(2021), Vol. 28, pp. 975-982, European Journal of Preventive Cardiology, England, C1

Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature

F Savira, R Magaye, D Liew, C Reid, D Kelly, A Kompa, S Sangaralingham, J Burnett, D Kaye, B Wang

(2020), Vol. 177, pp. 2906-2922, British Journal of Pharmacology, Chichester, Eng., C1

Exogenous dihydrosphingosine 1 phosphate mediates collagen synthesis in cardiac fibroblasts through JAK/STAT signalling and regulation of TIMP1

R Magaye, F Savira, Y Hua, X Xiong, L Huang, C Reid, B Flynn, D Kaye, D Liew, B Wang

(2020), Vol. 72, Cellular Signalling, England, C1

Inhibition of apoptosis signal-regulating kinase 1 ameliorates left ventricular dysfunction by reducing hypertrophy and fibrosis in a rat model of cardiorenal syndrome

F Savira, B Wang, A Edgley, B Jucker, R Willette, H Krum, D Kelly, A Kompa

(2020), Vol. 310, pp. 128-136, International Journal of Cardiology, Amsterdam, The Netherlands, C1

Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy

F Savira, R Magaye, Y Hua, D Liew, D Kaye, T Marwick, B Wang

(2019), Vol. 308, pp. 34-49, Toxicology Letters, Amsterdam, The Netherlands, C1

The role of dihydrosphingolipids in disease

R Magaye, F Savira, Y Hua, D Kelly, C Reid, B Flynn, D Liew, B Wang

(2019), Vol. 76, pp. 1107-1134, Cellular and Molecular Life Sciences, Basel, Switzerland, C1

Inhibition of Apoptosis Signal-Regulating Kinase 1 Attenuates Myocyte Hypertrophy and Fibroblast Collagen Synthesis

W Yang, B Wang, I Wang, L Huang, F Savira, A Kompa, B Jucker, R Willette, D Kelly, H Krum, Z Li, Q Fu

(2019), Vol. 28, pp. 495-504, Heart Lung and Circulation, Australia, C1

Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome

F Savira, L Cao, I Wang, W Yang, K Huang, Y Hua, B Jucker, R Willette, L Huang, H Krum, Z Li, Q Fu, B Wang

(2017), Vol. 12, PLoS ONE, United States, C1